Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Tegoprazan Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel route for Tegoprazan intermediate via oxazole protection. High purity, scalable process for API manufacturing cost reduction.
Novel asymmetric reduction route ensures high ee value and yield for Tegoprazan intermediate, offering significant supply chain stability and cost optimization for global pharmaceutical manufacturing partners.
Novel scalable route for tegoprazan key intermediate offering high purity ≥99% and simplified post-processing for reliable pharmaceutical supply chains.